News and Announcements
Phylogica (ASX:PYC) Shareholder Newsletter Update
- Published September 05, 2013 11:21AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Topics:
- Phylogica launches a new disruptive technology: the Endosome Escape Trap
- Janssen expansion driven by delivery on goals of CPP discovery project
- Appointment of Dr Richard Hopkins as CEO
- Management changes extend cash runway while maintaining focus on delivery
- Maintaining focus on Phylogica’s business development activities
- New patents strengthen Phylogica’s IP estate
- Grant to fund biosensor development collaboration with University of Queensland
- Recent antimicrobials deal with Cubist Pharmaceuticals
To read the Shareholder Update please download the document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
